Year | Women in target period | Epidemic period (January–May) | Non-epidemic period (June–December) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cumulative days absent | Per woman | 95% CI+ | 95% CI− | Per month | Cumulative days absent | Per woman | 95% CI+ | 95% CI− | Per month | ||
2003 | 56 | ||||||||||
2004 | 57 | 98 | 1.750 | 2.252 | 1.247 | 0.350 | 76 | 1.357 | 1.764 | 0.950 | 0.194 |
2005 | 62 | 97 | 1.702 | 2.234 | 1.168 | 0.340 | 27 | 0.474 | 0.742 | 0.204 | 0.068 |
2006 | 66 | 98 | 1.581 | 2.048 | 1.113 | 0.316 | 58 | 0.935 | 1.309 | 0.561 | 0.134 |
2007 | 80 | 109 | 1.652 | 2.116 | 1.186 | 0.330 | 54 | 0.818 | 1.151 | 0.485 | 0.117 |
2008 | 65 | 148 | 1.850 | 2.285 | 1.414 | 0.370 | 67 | 0.838 | 1.136 | 0.538 | 0.120 |
2009 | 62 | 65 | 1.000 | 1.346 | 0.653 | 0.200 | 39 | 0.600 | 0.900 | 0.299 | 0.086 |
2010 | 96 | 63 | 1.016 | 1.354 | 0.677 | 0.203 | 66 | 1.065 | 1.484 | 0.644 | 0.152 |
2011 | 114 | 64 | 0.667 | 0.907 | 0.426 | 0.133 | 68 | 0.708 | 1.049 | 0.491 | 0.101 |
2012 | 98 | 0.860 | 1.113 | 0.588 | 0.172 | 84 | 0.737 | 0.972 | 0.501 | 0.105 |